The HEPSANET score to assess treatment eligibility of chronic hepatitis B in Africa

Lancet Gastroenterol Hepatol. 2024 Jul;9(7):589. doi: 10.1016/S2468-1253(24)00114-6.
No abstract available

Publication types

  • Letter

MeSH terms

  • Africa / epidemiology
  • Antiviral Agents* / therapeutic use
  • Eligibility Determination
  • Hepatitis B, Chronic* / drug therapy
  • Hepatitis B, Chronic* / epidemiology
  • Humans

Substances

  • Antiviral Agents